<code id='C2410A476D'></code><style id='C2410A476D'></style>
    • <acronym id='C2410A476D'></acronym>
      <center id='C2410A476D'><center id='C2410A476D'><tfoot id='C2410A476D'></tfoot></center><abbr id='C2410A476D'><dir id='C2410A476D'><tfoot id='C2410A476D'></tfoot><noframes id='C2410A476D'>

    • <optgroup id='C2410A476D'><strike id='C2410A476D'><sup id='C2410A476D'></sup></strike><code id='C2410A476D'></code></optgroup>
        1. <b id='C2410A476D'><label id='C2410A476D'><select id='C2410A476D'><dt id='C2410A476D'><span id='C2410A476D'></span></dt></select></label></b><u id='C2410A476D'></u>
          <i id='C2410A476D'><strike id='C2410A476D'><tt id='C2410A476D'><pre id='C2410A476D'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:6168
          James Comer -- coverage from STAT
          Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

          WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

          Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

          advertisement

          Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown
          China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

          FILE-HongKong'sChiefExecutiveJohnLeegivesaspeechfollowingaswearing-inceremonytoinauguratethecity'sne

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          AbbVie dramatically boosts its spending on lobbying

          ThepharmagiantAbbViespentnearly$4milliononlobbyinginthefirstthreemonthsof2022—nearlyamilliondollarsm